Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 52

1.

Human T-Cell Lymphotropic Virus Type 1 Transactivator Tax Exploits the XPB Subunit of TFIIH during Viral Transcription.

Martella C, Tollenaere AI, Waast L, Lacombe B, Groussaud D, Margottin-Goguet F, Ramirez BC, Pique C.

J Virol. 2020 Mar 31;94(8). pii: e02171-19. doi: 10.1128/JVI.02171-19. Print 2020 Mar 31.

PMID:
32024775
2.

"Simulect" as a model compound for assessing placental transfer of monoclonal antibodies in minipigs.

Hey A, Hill M, Calonder C, DeLise AM, Grossi AB, Pique C, Marsden E.

Reprod Toxicol. 2020 Jan;91:142-146. doi: 10.1016/j.reprotox.2019.10.007. Epub 2019 Nov 4.

PMID:
31698003
3.

HTLV-1 HBZ Protein Resides Exclusively in the Cytoplasm of Infected Cells in Asymptomatic Carriers and HAM/TSP Patients.

Forlani G, Baratella M, Tedeschi A, Pique C, Jacobson S, Accolla RS.

Front Microbiol. 2019 Apr 26;10:819. doi: 10.3389/fmicb.2019.00819. eCollection 2019.

4.

A shortened study design for embryo-fetal development studies in the minipig.

Pique C, Marsden E, Quesada P, Blondel A, Mikkelsen LF.

Reprod Toxicol. 2018 Sep;80:35-43. doi: 10.1016/j.reprotox.2018.06.009. Epub 2018 Jun 22.

PMID:
29940329
5.

[Sweet hijacking by the Tax oncoprotein of the Human T-cell lymphotropic virus type 1].

Pique C, Issad T.

Med Sci (Paris). 2018 Feb;34(2):120-122. doi: 10.1051/medsci/20183402006. Epub 2018 Feb 16. French. No abstract available.

6.

Adult T cell leukemia aggressivenness correlates with loss of both 5-hydroxymethylcytosine and TET2 expression.

Marçais A, Waast L, Bruneau J, Hanssens K, Asnafi V, Gaulard P, Suarez F, Dubreuil P, Gessain A, Hermine O, Pique C.

Oncotarget. 2016 Nov 26;8(32):52256-52268. doi: 10.18632/oncotarget.13665. eCollection 2017 Aug 8.

7.

Hijacking of the O-GlcNAcZYME complex by the HTLV-1 Tax oncoprotein facilitates viral transcription.

Groussaud D, Khair M, Tollenaere AI, Waast L, Kuo MS, Mangeney M, Martella C, Fardini Y, Coste S, Souidi M, Benit L, Pique C, Issad T.

PLoS Pathog. 2017 Jul 24;13(7):e1006518. doi: 10.1371/journal.ppat.1006518. eCollection 2017 Jul.

8.

ALPK1 controls TIFA/TRAF6-dependent innate immunity against heptose-1,7-bisphosphate of gram-negative bacteria.

Milivojevic M, Dangeard AS, Kasper CA, Tschon T, Emmenlauer M, Pique C, Schnupf P, Guignot J, Arrieumerlou C.

PLoS Pathog. 2017 Feb 21;13(2):e1006224. doi: 10.1371/journal.ppat.1006224. eCollection 2017 Feb.

9.

Loss of infectivity of HIV-1 particles produced by mobile lymphocytes.

Chazal M, Nzounza P, Pique C, Ramirez BC.

PLoS One. 2014 Oct 8;9(10):e109601. doi: 10.1371/journal.pone.0109601. eCollection 2014.

10.

A non-SUMOylated tax protein is still functional for NF-κB pathway activation.

Pène S, Waast L, Bonnet A, Bénit L, Pique C.

J Virol. 2014 Sep;88(18):10655-61. doi: 10.1128/JVI.01827-14. Epub 2014 Jul 2.

11.

Human T cell leukemia virus type 2 tax-mediated NF-κB activation involves a mechanism independent of Tax conjugation to ubiquitin and SUMO.

Journo C, Bonnet A, Favre-Bonvin A, Turpin J, Vinera J, Côté E, Chevalier SA, Kfoury Y, Bazarbachi A, Pique C, Mahieux R.

J Virol. 2013 Jan;87(2):1123-36. doi: 10.1128/JVI.01792-12. Epub 2012 Nov 7.

12.

Pathways of cell-cell transmission of HTLV-1.

Pique C, Jones KS.

Front Microbiol. 2012 Oct 24;3:378. doi: 10.3389/fmicb.2012.00378. eCollection 2012.

13.

Low nuclear body formation and tax SUMOylation do not prevent NF-kappaB promoter activation.

Bonnet A, Randrianarison-Huetz V, Nzounza P, Nedelec M, Chazal M, Waast L, Pene S, Bazarbachi A, Mahieux R, Bénit L, Pique C.

Retrovirology. 2012 Sep 25;9:77. doi: 10.1186/1742-4690-9-77.

14.

The multifaceted oncoprotein Tax: subcellular localization, posttranslational modifications, and NF-κB activation.

Kfoury Y, Nasr R, Journo C, Mahieux R, Pique C, Bazarbachi A.

Adv Cancer Res. 2012;113:85-120. doi: 10.1016/B978-0-12-394280-7.00003-8. Review.

PMID:
22429853
15.

The scaffolding protein Dlg1 is a negative regulator of cell-free virus infectivity but not of cell-to-cell HIV-1 transmission in T cells.

Nzounza P, Chazal M, Guedj C, Schmitt A, Massé JM, Randriamampita C, Pique C, Ramirez BC.

PLoS One. 2012;7(1):e30130. doi: 10.1371/journal.pone.0030130. Epub 2012 Jan 17.

16.

Molecular aspects of HTLV-1 entry: functional domains of the HTLV-1 surface subunit (SU) and their relationships to the entry receptors.

Jones KS, Lambert S, Bouttier M, Bénit L, Ruscetti FW, Hermine O, Pique C.

Viruses. 2011 Jun;3(6):794-810. doi: 10.3390/v3060794. Epub 2011 Jun 15. Review.

17.

Current concepts regarding the HTLV-1 receptor complex.

Ghez D, Lepelletier Y, Jones KS, Pique C, Hermine O.

Retrovirology. 2010 Nov 29;7:99. doi: 10.1186/1742-4690-7-99. Review.

18.

Tax ubiquitylation and SUMOylation control the dynamic shuttling of Tax and NEMO between Ubc9 nuclear bodies and the centrosome.

Kfoury Y, Setterblad N, El-Sabban M, Zamborlini A, Dassouki Z, El Hajj H, Hermine O, Pique C, de Thé H, Saïb A, Bazarbachi A.

Blood. 2011 Jan 6;117(1):190-9. doi: 10.1182/blood-2010-05-285742. Epub 2010 Oct 19.

PMID:
20959607
19.

Free HTLV-1 induces TLR7-dependent innate immune response and TRAIL relocalization in killer plasmacytoid dendritic cells.

Colisson R, Barblu L, Gras C, Raynaud F, Hadj-Slimane R, Pique C, Hermine O, Lepelletier Y, Herbeuval JP.

Blood. 2010 Mar 18;115(11):2177-85. doi: 10.1182/blood-2009-06-224741. Epub 2009 Dec 10.

PMID:
20007807
20.

A role for CD81 on the late steps of HIV-1 replication in a chronically infected T cell line.

Grigorov B, Attuil-Audenis V, Perugi F, Nedelec M, Watson S, Pique C, Darlix JL, Conjeaud H, Muriaux D.

Retrovirology. 2009 Mar 11;6:28. doi: 10.1186/1742-4690-6-28.

21.

HTLV-1 uses HSPG and neuropilin-1 for entry by molecular mimicry of VEGF165.

Lambert S, Bouttier M, Vassy R, Seigneuret M, Petrow-Sadowski C, Janvier S, Heveker N, Ruscetti FW, Perret G, Jones KS, Pique C.

Blood. 2009 May 21;113(21):5176-85. doi: 10.1182/blood-2008-04-150342. Epub 2009 Mar 6.

22.

Alteration of blood-brain barrier integrity by retroviral infection.

Afonso PV, Ozden S, Cumont MC, Seilhean D, Cartier L, Rezaie P, Mason S, Lambert S, Huerre M, Gessain A, Couraud PO, Pique C, Ceccaldi PE, Romero IA.

PLoS Pathog. 2008 Nov;4(11):e1000205. doi: 10.1371/journal.ppat.1000205. Epub 2008 Nov 14.

23.

Human Discs Large is a new negative regulator of human immunodeficiency virus-1 infectivity.

Perugi F, Muriaux D, Ramirez BC, Chabani S, Decroly E, Darlix JL, Blot V, Pique C.

Mol Biol Cell. 2009 Jan;20(1):498-508. doi: 10.1091/mbc.E08-02-0189. Epub 2008 Oct 22.

24.

Ubiquitylated Tax targets and binds the IKK signalosome at the centrosome.

Kfoury Y, Nasr R, Favre-Bonvin A, El-Sabban M, Renault N, Giron ML, Setterblad N, Hajj HE, Chiari E, Mikati AG, Hermine O, Saib A, de Thé H, Pique C, Bazarbachi A.

Oncogene. 2008 Mar 13;27(12):1665-76. Epub 2007 Sep 24.

PMID:
17891179
25.
26.

Neuropilin-1 is involved in human T-cell lymphotropic virus type 1 entry.

Ghez D, Lepelletier Y, Lambert S, Fourneau JM, Blot V, Janvier S, Arnulf B, van Endert PM, Heveker N, Pique C, Hermine O.

J Virol. 2006 Jul;80(14):6844-54.

28.

Tax ubiquitylation and sumoylation control critical cytoplasmic and nuclear steps of NF-kappaB activation.

Nasr R, Chiari E, El-Sabban M, Mahieux R, Kfoury Y, Abdulhay M, Yazbeck V, Hermine O, de Thé H, Pique C, Bazarbachi A.

Blood. 2006 May 15;107(10):4021-9. Epub 2006 Jan 19.

PMID:
16424386
29.

Stable ubiquitination of human T-cell leukemia virus type 1 tax is required for proteasome binding.

Chiari E, Lamsoul I, Lodewick J, Chopin C, Bex F, Pique C.

J Virol. 2004 Nov;78(21):11823-32.

31.

Human Dlg protein binds to the envelope glycoproteins of human T-cell leukemia virus type 1 and regulates envelope mediated cell-cell fusion in T lymphocytes.

Blot V, Delamarre L, Perugi F, Pham D, Bénichou S, Benarous R, Hanada T, Chishti AH, Dokhélar MC, Pique C.

J Cell Sci. 2004 Aug 1;117(Pt 17):3983-93.

32.

Nedd4.1-mediated ubiquitination and subsequent recruitment of Tsg101 ensure HTLV-1 Gag trafficking towards the multivesicular body pathway prior to virus budding.

Blot V, Perugi F, Gay B, Prévost MC, Briant L, Tangy F, Abriel H, Staub O, Dokhélar MC, Pique C.

J Cell Sci. 2004 May 1;117(Pt 11):2357-67.

33.

Loss of the ex vivo but not the reinducible CD8+ T-cell response to Tax in human T-cell leukemia virus type 1-infected patients with adult T-cell leukemia/lymphoma.

Arnulf B, Thorel M, Poirot Y, Tamouza R, Boulanger E, Jaccard A, Oksenhendler E, Hermine O, Pique C.

Leukemia. 2004 Jan;18(1):126-32.

PMID:
14574331
34.

HTLV-1 structural proteins.

Le Blanc I, Grange MP, Delamarre L, Rosenberg AR, Blot V, Pique C, Dokhélar MC.

Virus Res. 2001 Oct 30;78(1-2):5-16. Review.

PMID:
11520576
35.

Human T cell leukemia virus Type I (HTLV-I) infection induces greater expansions of CD8 T lymphocytes in persons with HTLV-I-associated myelopathy/tropical spastic paraparesis than in asymptomatic carriers.

Ureta-Vidal A, Pique C, Garcia Z, Dehée A, Tortevoye P, Désiré N, Gessain A, Chancerel B, Gout O, Lemonnier FA, Cochet M.

J Infect Dis. 2001 Mar 15;183(6):857-64. Epub 2001 Feb 13.

PMID:
11237801
36.

In vivo production of Rof and Tof proteins of HTLV type 1: evidence from cytotoxic T lymphocytes.

Pique C, Dokhelar MC.

AIDS Res Hum Retroviruses. 2000 Nov 1;16(16):1783-6. No abstract available.

PMID:
11080827
37.

Interaction of CD82 tetraspanin proteins with HTLV-1 envelope glycoproteins inhibits cell-to-cell fusion and virus transmission.

Pique C, Lagaudrière-Gesbert C, Delamarre L, Rosenberg AR, Conjeaud H, Dokhélar MC.

Virology. 2000 Oct 25;276(2):455-65.

38.

Evidence for the chronic in vivo production of human T cell leukemia virus type I Rof and Tof proteins from cytotoxic T lymphocytes directed against viral peptides.

Pique C, Ureta-Vidal A, Gessain A, Chancerel B, Gout O, Tamouza R, Agis F, Dokhélar MC.

J Exp Med. 2000 Feb 7;191(3):567-72.

39.

The Y-S-L-I tyrosine-based motif in the cytoplasmic domain of the human T-cell leukemia virus type 1 envelope is essential for cell-to-cell transmission.

Delamarre L, Pique C, Rosenberg AR, Blot V, Grange MP, Le Blanc I, Dokhélar MC.

J Virol. 1999 Nov;73(11):9659-63.

40.

Early assembly step of a retroviral envelope glycoprotein: analysis using a dominant negative assay.

Rosenberg AR, Delamarre L, Pique C, Le Blanc I, Griffith G, Dokhélar MC.

J Cell Biol. 1999 Apr 5;145(1):57-68.

41.

Endomitosis of human megakaryocytes are due to abortive mitosis.

Vitrat N, Cohen-Solal K, Pique C, Le Couedic JP, Norol F, Larsen AK, Katz A, Vainchenker W, Debili N.

Blood. 1998 May 15;91(10):3711-23.

PMID:
9573008
42.

The ectodomain of the human T-cell leukemia virus type 1 TM glycoprotein is involved in postfusion events.

Rosenberg AR, Delamarre L, Pique C, Pham D, Dokhélar MC.

J Virol. 1997 Oct;71(10):7180-6.

43.
45.

The HTLV-I envelope glycoproteins: structure and functions.

Delamarre L, Rosenberg AR, Pique C, Pham D, Callebaut I, Dokhélar MC.

J Acquir Immune Defic Syndr Hum Retrovirol. 1996;13 Suppl 1:S85-91. Review.

PMID:
8797709
46.

Identification of functional regions in the human T-cell leukemia virus type I SU glycoprotein.

Delamarre L, Pique C, Pham D, Tursz T, Dokhélar MC.

J Virol. 1994 Jun;68(6):3544-9.

47.

The open reading frame I (ORF I)/ORF II part of the human T-cell leukemia virus type I X region is dispensable for p40tax, p27rex, or envelope expression.

Roithmann S, Pique C, Le Cesne A, Delamarre L, Pham D, Tursz T, Dokhélar MC.

J Virol. 1994 May;68(5):3448-51.

48.

Functional comparison between HTLV-I envelopes originating from TSP/HAM or ATL cell lines.

Pique C, Saal F, Périès J, Pham D, Tursz T, Dokhélar MC.

J Acquir Immune Defic Syndr (1988). 1994 Apr;7(4):319-24.

PMID:
8133444
50.

Supplemental Content

Support Center